Concepedia

Richard Chalmers

RC

Statistics

Publications

13

Citations

1.7K

H-Index

13

Active since

2003

Affiliations

King's College London(Current)

University of Bristol

University of Oxford

University of Nottingham

Nottingham University Hospitals NHS Trust

Richard Chalmers is an author at King's College London specializing in medicine, pharmacotherapy, and 28-day mortality.

Publications per year

2003–2024

13

Publications

13

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +11

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +13

Management of cutaneous metastases using electrochemotherapy

Louise Wichmann Matthiessen, Richard Chalmers, David Sainsbury et al. · Acta Oncologica · 2011 · 146 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

1–5 of 13